NEW YORK (GenomeWeb News) - A consortium of Texas research institutions studying genomics and disease will use Invitrogen’s siRNA library and screening tools to study cancer, diabetes, and metabolic disorders, the company said today.
Researchers at six locations, including the University of Texas at Houston and at Galveston, Baylor College, M.D. Anderson Cancer Center, and Rice University, will use Invitrogen’s human kinase and human and mouse nuclear receptor collections in high-throughput image-based screening and gene expression experimental research.
The consortium, known as the Gulf Coast Consortium for Chemical Genomics, will use Invitrogen’s SYBR GreenER qPCR technology, and its Molecular Probes image tools to measure various effects on siRNA molecules.
Financial terms of the agreement were not released.